Deutsche Bank
YTEN

Deutsche Bank’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Deutsche Bank’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$1K – 5603
2018
Q2 		$1K Buy
+1
New +$1.58K ﹤0.01% 5361
2018
Q1 		– Hold
0
– – – 5652
2017
Q4 		– Hold
0
– – – 5194
2017
Q3 		– Sell
-1
Closed -$2.81K – 5140
2017
Q2 		$4K Buy
+1
New +$4.68K ﹤0.01% 4786
2017
Q1 		– Hold
0
– – – 5148
2016
Q4 		– Hold
0
– – – 5112
2016
Q3 		– Hold
0
– – – 5259
2016
Q2 		– Hold
0
– – – 5384
2015
Q1 		– Hold
0
– -$8K – 6106
2014
Q4 		– Hold
0
– – – 5772
2014
Q2 		– Hold
0
– -$1K – 6112
2014
Q1 		– Hold
0
– – – 5502
2013
Q4 		– Hold
0
– -$14K – 5765
2013
Q3 		– Hold
0
– – – 4970
2013
Q2 		– Hold
0
– – – 4835

Other funds holding YTEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's YTEN Position: Q3 2018 in Review

Deutsche Bank sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2018, closing a stake of 1 share — an estimated $1K sold.

Deutsche Bank first reported a position in YTEN in Q2 2017 and held it in 2 quarters. The position peaked at $4K in Q2 2017. 13 funds tracked by Wall St. Rank hold YTEN as of Q3 2018.

  • Deutsche Bank reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Deutsche Bank sold 1 Yield10 Bioscience, Inc. Common Stock share in Q3 2018, an estimated $1K.
  • Deutsche Bank first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Deutsche Bank's Yield10 Bioscience, Inc. Common Stock position peaked at $4K in Q2 2017.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2018.

Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.